|
|
Prepublished online as a Blood First Edition Paper on November 14, 2002; DOI 10.1182/blood-2002-08-2379.
Submitted August 9, 2002
Accepted September 22, 2002
Anti-CD45-mediated cytoreduction to facilitate allogeneic stem cell transplantation
Gerald G Wulf, Kang-Li Luo, Margaret A Goodell, and Malcolm K Brenner*
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA
* Corresponding author; email: mbrenner{at}bcm.tmc.edu.
The CD45 antigen is present on all cells of the hematopoietic lineage. Using a murine model, we have determined whether a lytic CD45 monoclonal antibody can produce persistent aplasia and whether it could facilitate syngeneic or allogeneic stem cell engraftment. After its systemic administration, we found saturating quantities of the antibody on all cells expressing the CD45 antigen, both in marrow and in lymphoid organs. All leukocyte subsets in peripheral blood were markedly diminished during or soon after anti-CD45 treatment, but only the effect on the lymphoid compartment was sustained. In contrast to the prolonged depletion of T and B lymphocytes from the thymus and spleen, peripheral blood neutrophils began to recover within 24 hours after the first anti-CD45 injection and marrow progenitor cells were spared from destruction, despite being coated with saturating quantities of anti-CD45. Given the transient effects of the monoclonal antibody on myelopoiesis and the more persistent effects on lymphopoiesis, we asked whether this agent could contribute to donor hemopoietic engraftment following subablativenon-myeloablative transplantation. Treatment with anti-CD45 alone did not enhance syngeneic engraftment, consistent with its inability to destroy progenitor cells and permit competitive repopulation with syngeneic donor stem cells. By contrast, the combination of anti-CD45 and an otherwise inactive dose of total-body irradiation allowed engraftment of H2 fully allogeneic donor stem cells. We attribute this result to the recipient immunosuppression produced by depletion of CD45-positive lymphocytes. Monoclonal antibodies of this type may therefore have an adjunctive role in subablativenon-myeloablative conditioning regimens for allogeneic stem cell transplantation.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
X. Zhang, L. Shen, Y. Jin, D. R. Saban, S. K. Chauhan, and R. Dana
Depletion of Passenger Leukocytes from Corneal Grafts: An Effective Means of Promoting Transplant Survival?
Invest. Ophthalmol. Vis. Sci.,
July 1, 2009;
50(7):
3137 - 3144.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. U. Louis, K. Straathof, C. M. Bollard, C. Gerken, M. H. Huls, M. V. Gresik, M.-F. Wu, H. L. Weiss, A. P. Gee, M. K. Brenner, et al.
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients
Blood,
March 12, 2009;
113(11):
2442 - 2450.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F.-J. Li, N. Tsuyama, H. Ishikawa, M. Obata, S. Abroun, S. Liu, K.-i. Otsuyama, X. Zheng, Z. Ma, Y. Maki, et al.
A rapid translocation of CD45RO but not CD45RA to lipid rafts in IL-6-induced proliferation in myeloma
Blood,
April 15, 2005;
105(8):
3295 - 3302.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
